“Our team is relentlessly focused on developing solutions that specifically address the needs of our customers. Our latest products demonstrate our focus on addressing key bioprocessing bottlenecks and manufacturing inefficiencies during process development,” said
The first-of-its-kind AAV-Tek AEX Buffer Screening Kit helps AAV gene therapy developers identify the ideal buffer formulation for use during AAV downstream processing, specifically during the anion exchange (AEX) purification step. Available for AAV2, AAV8 – and now AAV6 – Teknova rigorously tested each serotype-specific version of the kit with a robust design of experiments approach that included hundreds of runs and validation against four critical quality attributes: infectivity, recovery, purity, and peak separation. Every version of the kit includes a unique selection of serotype-specific equilibration and elution buffers designed to optimize the separation of empty and full capsids during polishing and can save AAV gene therapy developers months of process development time.
Teknova is also introducing an extensive suite of high-quality off-the-shelf reagents to support the end-to-end plasmid workflow process, from culture media to buffers and reagents for use throughout the pDNA growth and purification process. With solutions available for selection and culturing, as well as purification and recovery, Teknova has more than 60 existing formulations to help customers expedite plasmid production to ensure reproducibility and scalability throughout the discovery and commercialization process.
Through the combination of new, proprietary products alongside off-the-shelf reagents that enable bioprocessing workflows, Teknova continues to be uniquely positioned as a multi-platform, single-source partner for customers in cell and gene therapy, molecular diagnostics, and synthetic biology, particularly as they scale from process development to clinical-stage production.
The AAV-Tek AEX Buffer Screening Kit for AAV6 is available today for purchase via phone, email, or online, and is priced at
For more information about the AAV-Tek AEX Buffer Screening Kit or to purchase it online, visit http://www.teknova.com/AAV6.
For more information about the suite of plasmid workflow solutions or to purchase them online, visit http://www.teknova.com/plasmid-workflow.
ABOUT TEKNOVA
Teknova makes solutions possible. Since 1996, Teknova has been innovating the manufacture of critical reagents for the life sciences industry to accelerate the discovery and development of novel therapies that will help people live longer, healthier lives. We offer fully customizable solutions for every stage of the workflow, supporting industry leaders in cell and gene therapy, molecular diagnostics, and synthetic biology. Our fast turnaround of high-quality agar plates, microbial culture media, buffers and reagents, and water helps our customers scale seamlessly from RUO to GMP. Headquartered in
Investor ContactsMatt Lowell Chief Financial Officer matt.lowell@teknova.com +1 831-637-1100Sara Michelmore MacDougall Advisors smichelmore@macdougall.bio +1 781-235-3060 Media ContactJennifer Henry Senior Vice President, Marketing jenn.henry@teknova.com +1 831-313-1259
Source:
2023 GlobeNewswire, Inc., source